260
Views
22
CrossRef citations to date
0
Altmetric
Review

Targeting invading macrophage- derived PGE2, IL-6 and calcitonin gene-related peptide in injured nerve to treat neuropathic pain

&
Pages 533-546 | Published online: 18 Jul 2006

Bibliography

  • LIEFNER M, SIEBERT H, SACHSE T, MICHEL U, KOLLIAS G, BRUCK W: The role of TNF-alpha during Wallerian degeneration. J. Neuroimmunol. (2000) 108(1-2):147-152.
  • MOALEM G, TRACEY DJ: Immune and inflammatory mechanisms in neuropathic pain. Brain Res. Rev. (2005) In Press.
  • MAKWANA M, RAIVICH G: Molecular mechanisms in successful peripheral regeneration. FEBS J. (2005) 272(11):2628-2638.
  • LIU T, VAN ROOIJEN N, TRACEY DJ: Depletion of macrophages reduces axonal degeneration and hyperalgesia following nerve injury. Pain (2000) 86(1-2):25-32.
  • ABBADIE C, LINDIA JA, CUMISKEY AM et al.: Impaired neuropathic pain responses in mice lacking the chemokine receptor CCR2. Proc. Natl. Acad. Sci. USA (2003) 100(13):7947-7952.
  • DJOUHRI L, KOUTSIKOU S, FANG X, MCMULLAN S, LAWSON SN: Spontaneous pain, both neuropathic and inflammatory, is related to frequency of spontaneous firing in intact C-fiber nociceptors. J. Neurosci. (2006) 26(4):1281-1292.
  • MICHAELIS M, VOGEL C, BLENK KH, ARNARSON A, JANIG W: Inflammatory mediators sensitize acutely axotomized nerve fibers to mechanical stimulation in the rat. J. Neurosci. (1998) 18(18):7581-7587.
  • XIE W, STRONG JA, MEIJ JT, ZHANG JM, YU L: Neuropathic pain: early spontaneous afferent activity is the trigger. Pain (2005) 116(3):243-256.
  • DURRENBERGER PF, FACER P, CASULA MA et al.: Prostanoid receptor EP1 and COX-2 in injured human nerves and a rat model of nerve injury: a time-course study. BMC. Neurol. (2006) 6:1-11.
  • MA W, EISENACH JC: Morphological and pharmacological evidence for the role of peripheral prostaglandins in the pathogenesis of neuropathic pain. Eur. J. Neurosci. (2002) 15(6):1037-1047.
  • MA W, QUIRION R: Up-regulation of interleukin 6 induced by prostaglandin 2 from invading macrophages following nerve injury: an in vivo and in vitro study. J. Neurochem. (2005) 93(3):664-673.
  • SCHAFERS M, MARZINIAK M, SORKIN LS, YAKSH TL, SOMMER C: Cyclooxygenase inhibition in nerve-injury- and TNF-induced hyperalgesia in the rat. Exp. Neurol. (2004) 185(1):160-168.
  • MA W, EISENACH JC: Cyclooxygenase 2 in infiltrating inflammatory cells in injured nerve is universally up-regulated following various types of nerve injury. Neuroscience (2003) 121(3):691-704.
  • DURRENBERGER PF, FACER P, GRAY RA et al.: Cyclooxygenase-2 (COX-2) in injured human nerve and a rat model of nerve injury. J. Peripher. Nerv. Syst. (2004) 9(1):15-25.
  • MUJA N, DEVRIES GH: Prostaglandin E(2) and 6-keto-prostaglandin F(1alpha) production is elevated following traumatic injury to sciatic nerve. Glia (2004) 46(2):116-129.
  • SYRIATOWICZ JP, HU D, WALKER JS, TRACEY DJ: Hyperalgesia due to nerve injury: role of prostaglandins. Neuroscience (1999) 94(2):587-594.
  • GRAHAM DJ, CAMPEN D, HUI R et al.: Risk of acute myocardial infarction and sudden cardiac death in patients treated with cyclo-oxygenase 2 selective and non-selective non-steroidal anti-inflammatory drugs: nested case-control study. Lancet (2005) 365(9458):475-481.
  • LINDHOLM D, HEUMANN R, MEYER M, THOENEN H: Interleukin-1 regulates synthesis of nerve growth factor in non- neuronal cells of the rat sciatic nerve. Nature (1987) 330(6149):658-659.
  • BROWN MC, PERRY VH, LUNN ER, GORDON S, HEUMANN R: Macrophage dependence of peripheral nerve regeneration: possible involvement of nerve growth factor. Neuron (1991) 6(3):359-370.
  • WAGNER R, MYERS RR: Schwann cells produce tumor necrosis factor alpha: expression in injured and non-injured nerves. Neuroscience (1996) 73(3):625-629.
  • SHUBAYEV VI, MYERS RR: Axonal transport of TNF-alpha in painful neuropathy: distribution of ligand tracer and TNF receptors. J. Neuroimmunol. (2001) 114(1-2):48-56.
  • WAGNER R, MYERS RR: Endoneurial injection of TNF-alpha produces neuropathic pain behaviors. Neuroreport (1996) 7(18):2897-2901.
  • FUKUOKA H, KAWATANI M, HISAMITSU T, TAKESHIGE C: Cutaneous hyperalgesia induced by peripheral injection of interleukin-1 beta in the rat. Brain Res. (1994) 657(3):133-140.
  • MAIER JA, HLA T, MACIAG T: Cyclooxygenase is an immediate-early gene induced by interleukin-1 in human endothelial cells. J. Biol. Chem. (1990) 265(19):10805-10808.
  • SAMAD TA, MOORE KA, SAPIRSTEIN A, BILLET S, ALLCHORNE A, POOLE S, BONVENTRE JV, WOOLF CJ: Interleukin-1beta-mediated induction of COX-2 in the CNS contributes to inflammatory pain hypersensitivity. Nature (2001) 410(6827):471-475.
  • FOURNIER T, FADOK V, HENSON PM: Tumor necrosis factor-alpha inversely regulates prostaglandin D2 and prostaglandin E2 production in murine macrophages. Synergistic action of cyclic AMP on cyclooxygenase-2 expression and prostaglandin E2 synthesis. J. Biol. Chem. (1997) 272(49):31065-31072.
  • MARSHALL JS, GOMI K, BLENNERHASSETT MG, BIENENSTOCK J: Nerve growth factor modifies the expression of inflammatory cytokines by mast cells via a prostanoid-dependent mechanism. J. Immunol. (1999) 162(7):4271-4276.
  • KAPLAN MD, OLSCHOWKA JA, O’BANION MK: Cyclooxygenase-1 behaves as a delayed response gene in PC12 cells differentiated by nerve growth factor. J. Biol. Chem. (1997) 272(30):18534-18537.
  • SUBANG MC, RICHARDSON PM: Influence of injury and cytokines on synthesis of monocyte chemoattractant protein-1 mRNA in peripheral nervous tissue. Eur. J. Neurosci. (2001) 13(3):521-528.
  • SIEBERT H, SACHSE A, KUZIEL WA, MAEDA N, BRUCK W: The chemokine receptor CCR2 is involved in macrophage recruitment to the injured peripheral nervous system. J. Neuroimmunol. (2000) 110(1-2):177-185.
  • TANAKA S, TATSUGUCHI A, FUTAGAMI S et al.: Monocyte chemoattractant protein 1 and macrophage cyclooxygenase 2 expression in colonic adenoma. Gut (2006) 55(1):54-61.
  • MASUKO-HONGO K, SATO T, NISHIOKA K: Chemokines differentially induce matrix metalloproteinase-3 and prostaglandin E2 in human articular chondrocytes. Clin. Exp. Rheumatol. (2005) 23(1):57-62.
  • NAKAYAMA T, MUTSUGA N, YAO L, TOSATO G: Prostaglandin E2 promotes degranulation-independent release of MCP-1 from mast cells. J. Leukoc. Biol. (2006) 79(1):95-104.
  • TWINING CM, SLOANE EM, MILLIGAN ED et al.: Peri-sciatic proinflammatory cytokines, reactive oxygen species, and complement induce mirror-image neuropathic pain in rats. Pain (2004) 110(1-2):299-309.
  • NAIK AK, TANDAN SK, DUDHGAONKAR SP et al.: Role of oxidative stress in pathophysiology of peripheral neuropathy and modulation by N-acetyl-l-cysteine in rats. Eur. J. Pain (2005) Epub ahead of print.
  • NAGATA M: Inflammatory cells and oxygen radicals. Curr. Drug Targets Inflamm. Allergy (2005) 4(4):503-504.
  • WANG T, QIN L, LIU B et al.: Role of reactive oxygen species in LPS-induced production of prostaglandin E2 in microglia. J. Neurochem. (2004) 88(4):939-947.
  • LU Y, WAHL LM: Oxidative stress augments the production of matrix metalloproteinase-1, cyclooxygenase-2, and prostaglandin E2 through enhancement of NF-kappa B activity in lipopolysaccharide-activated human primary monocytes. J. Immunol. (2005) 175(8):5423-5429.
  • VANEGAS H, SCHAIBLE HG: Prostaglandins and cycloxygenases in the spinal cord. Prog. Neurobiol. (2001) 64(4):327-363.
  • TAIWO YO, LEVINE JD: Prostaglandin effects after elimination of indirect hyperalgesic mechanisms in the skin of the rat. Brain Res. (1989) 492(1-2):397-399.
  • MORIYAMA T, HIGASHI T, TOGASHI K et al.: Sensitization of TRPV1 by EP1 and IP reveals peripheral nociceptive mechanism of prostaglandins. Mol. Pain (2005) 1(1):3-16.
  • MA W, QUIRION R: Increased phosphorylation of cyclic AMP responsive binding protein (CREB) in the superficial dorsal horn neurons following partial sciatic nerve ligation. Pain (2001) 93(3):295-301.
  • MA W, HATZIS C, EISENACH JC: Intrathecal injection of cAMP response element binding protein (CREB) antisense oligonucleotide attenuates tactile allodynia caused by partial sciatic nerve ligation. Brain Res. (2003) 988(1-2):97-104.
  • MA W, EISENACH JC: Four EP receptors are up-regulated in injured nerve following partial sciatic nerve ligation. Exp. Neurol. (2003) 183(2):581-592.
  • BOURDE O, KIEFER R, TOYKA KV, HARTUNG HP: Quantification of interleukin-6 mRNA in wallerian degeneration by competitive reverse transcription polymerase chain reaction. J. Neuroimmunol. (1996) 69(1-2):135-140.
  • CUI JG, HOLMIN S, MATHIESEN T, MEYERSON BA, LINDEROTH B: Possible role of inflammatory mediators in tactile hypersensitivity in rat models of mononeuropathy. Pain (2000) 88(3):239-248.
  • KOZAWA O, SUZUKI A, TOKUDA H, KAIDA T, UEMATSU T: Interleukin-6 synthesis induced by prostaglandin E2: cross-talk regulation by protein kinase C. Bone (1998) 22(4):355-360.
  • WILLIAMS JA, SHACTER E: Regulation of macrophage cytokine production by prostaglandin E2. Distinct roles of cyclooxygenase-1 and -2. J. Biol. Chem. (1997) 272(41):25693-25699.
  • YAMANE H, SUGIMOTO Y, TANAKA S, ICHIKAWA A: Prostaglandin E(2) receptors, EP2 and EP4, differentially modulate TNF-alpha and IL-6 production induced by lipopolysaccharide in mouse peritoneal neutrophils. Biochem. Biophys. Res. Commun. (2000) 278(1):224-228.
  • MURPHY PG, RAMER MS, BORTHWICK L, GAULDIE J, RICHARDSON PM, BISBY MA: Endogenous interleukin-6 contributes to peripheral neurophathic pain. Eur. J. Neurosci. (1999) 11(7):2243-2253.
  • XU XJ, HAO JX, ANDELL-JONSSON S, POLI V, BARTFAI T, WIESENFELD-HALLIN Z: Nociceptive responses in interleukin-6-deficient mice to peripheral inflammation and peripheral nerve section. Cytokine (1997) 9(12):1028-1033.
  • MA W, QUIRION R: Increased calcitonin gene-related peptide in neuroma and invading macrophages is involved in the up-regulation of interleukin-6 and nerve injury associated thermal hyperalgesia in a rat model of mononeuropathy. J. Neurochem. (2006) 98:180-192.
  • LIU HM, LEI HY, KAO KP: Correlation between NGF levels in wound chamber fluid and cytological localization of NGF and NGF receptor in axotomized rat sciatic nerve. Exp. Neurol. (1995) 132(1):24-32.
  • MALLAT M, HOULGATTE R, BRACHET P, PROCHIANTZ A: Lipopolysaccharide-stimulated rat brain macrophages release NGF in vitro. Dev. Biol. (1989) 133(1):309-311.
  • MARCINKIEWICZ M, MARCINKIEWICZ J, CHEN A, LECLAIRE F, CHRETIEN M, RICHARDSON P: Nerve growth factor and proprotein convertases furin and PC7 in transected sciatic nerves and in nerve segments cultured in conditioned media: their presence in Schwann cells, macrophages, and smooth muscle cells. J. Comp. Neurol. (1999) 403(4):471-485.
  • FRIEDMAN WJ, LARKFORS L, AYER-LELIEVRE C, EBENDAL T, OLSON L, PERSSON H: Regulation of beta-nerve growth factor expression by inflammatory mediators in hippocampal cultures. J. Neurosci. Res. (1990) 27(3):374-382.
  • PETRUSKA JC, MENDELL LM: The many functions of nerve growth factor: multiple actions on nociceptors. Neurosci. Lett. (2004) 361(1-3):168-171.
  • LEVY D, KUBES P, ZOCHODNE DW: Delayed peripheral nerve degeneration, regeneration, and pain in mice lacking inducible nitric oxide synthase. J. Neuropathol. Exp. Neurol. (2001) 60(5):411-421.
  • LEVY D, HOKE A, ZOCHODNE DW: Local expression of inducible nitric oxide synthase in an animal model of neuropathic pain. Neurosci. Lett. (1999) 260(3):207-209.
  • ALEY KO, MCCARTER G, LEVINE JD: Nitric oxide signaling in pain and nociceptor sensitization in the rat. J. Neurosci. (1998) 18(17):7008-7014.
  • CHANG YH, LEE ST, LIN WW: Effects of cannabinoids on LPS-stimulated inflammatory mediator release from macrophages: involvement of eicosanoids. J. Cell Biochem. (2001) 81(4):715-723.
  • PANARO MA, BRANDONISIO O, SISTO M et al.: Nitric oxide production by Leishmania-infected macrophages and modulation by prostaglandin E2. Clin. Exp. Med. (2001) 1(3):137-143.
  • HRABAK A, VERCRUYSSE V, KAHAN IL, VRAY B: Indomethacin prevents the induction of inducible nitric oxide synthase in murine peritoneal macrophages and decreases their nitric oxide production. Life Sci. (2001) 68(16):1923-1930.
  • WOESSNER JF Jr: MMPs and TIMPs - an historical perspective. Mol. Biotechnol. (2002) 22(1):33-49.
  • YONG VW, KREKOSKI CA, FORSYTH PA, BELL R, EDWARDS DR: Matrix metalloproteinases and diseases of the CNS. Trends Neurosci. (1998) 21(2):75-80.
  • LA FLEUR M, UNDERWOOD JL, RAPPOLEE DA, WERB Z: Basement membrane and repair of injury to peripheral nerve: defining a potential role for macrophages, matrix metalloproteinases, and tissue inhibitor of metalloproteinases-1. J. Exp. Med. (1996) 184(6):2311-2326.
  • SHUBAYEV VI, MYERS RR: Endoneurial remodeling by TNFalph- and TNFalpha-releasing proteases. A spatial and temporal co-localization study in painful neuropathy. J. Peripher. Nerv. Syst. (2002) 7(1):28-36.
  • TALHOUK RS, HAJJAR L, ABOU-GERGI R et al.: Functional interplay between gelatinases and hyperalgesia in endotoxin-induced localized inflammatory pain. Pain (2000) 84(2-3):397-405.
  • SOMMER C, SCHMIDT C, GEORGE A, TOYKA KV: A metalloprotease-inhibitor reduces pain associated behavior in mice with experimental neuropathy. Neurosci. Lett. (1997) 237(1):45-48.
  • PAVLOVIC S, DU B, SAKAMOTO K et al.: Targeting prostaglandin E2 receptors as an alternative strategy to block cyclooxygenase-2-dependent extracellular matrix-induced matrix metalloproteinase-9 expression by macrophages. J. Biol. Chem. (2006) 281(6):3321-3328.
  • BOTTNER M, KRIEGLSTEIN K, UNSICKER K: The transforming growth factor-betas: structure, signaling, and roles in nervous system development and functions. J. Neurochem. (2000) 75(6):2227-2240.
  • LINDHOLM D, CASTREN E, KIEFER R, ZAFRA F, THOENEN H: Transforming growth factor-beta 1 in the rat brain: increase after injury and inhibition of astrocyte proliferation. J. Cell Biol. (1992) 117(2):395-400.
  • MOON LD, FAWCETT JW: Reduction in CNS scar formation without concomitant increase in axon regeneration following treatment of adult rat brain with a combination of antibodies to TGFbeta1 and beta2. Eur. J. Neurosci. (2001) 14(10):1667-1677.
  • RUFER M, FLANDERS K, UNSICKER K: Presence and regulation of transforming growth factor beta mRNA and protein in the normal and lesioned rat sciatic nerve. J. Neurosci. Res. (1994) 39(4):412-423.
  • REDING TV, BIMMLER DR, PERREN A et al.: A selective COX-2 inhibitor suppresses chronic pancreatitis in an animal model (WBN/Kob rats): significant reduction of macrophage infiltration and fibrosis. Gut (2005) Epub ahead of print.
  • JENSEN TS, GOTTRUP H, SINDRUP SH, BACH FW: The clinical picture of neuropathic pain. Eur. J. Pharmacol. (2001) 429(1-3):1-11.
  • OKAMOTO K, MARTIN DP, SCHMELZER JD, MITSUI Y, LOW PA: Pro- and anti-inflammatory cytokine gene expression in rat sciatic nerve chronic constriction injury model of neuropathic pain. Exp. Neurol. (2001) 169(2):386-391.
  • MURPHY PG, GRONDIN J, ALTARES M, and RICHARDSON PM: Induction of interleukin-6 in axotomized sensory neurons. J. Neurosci. (1995) 15(7):5130-5138.
  • AKAOGI J, YAMADA H, KURODA Y, NACIONALES DC, REEVES WH, SATOH M: Prostaglandin E2 receptors EP2 and EP4 are up-regulated in peritoneal macrophages and joints of pristane-treated mice and modulate TNF-alpha and IL-6 production. J. Leukoc. Biol. (2004) 76(1):227-236.
  • REILLY CA, JOHANSEN ME, LANZA DL, LEE J, LIM JO, YOST GS: Calcium-dependent and independent mechanisms of capsaicin receptor (TRPV1)-mediated cytokine production and cell death in human bronchial epithelial cells. J. Biochem. Mol. Toxicol. (2005) 19(4):266-275.
  • EVANS R, SHULTZ LD, DRANOFF G, FULLER JA, KAMDAR SJ: CSF-1 regulation of Il6 gene expression by murine macrophages: a pivotal role for GM-CSF. J. Leukoc. Biol. (1998) 64(6):810-816.
  • OPREE A, KRESS M: Involvement of the proinflammatory cytokines tumor necrosis factor-alpha, IL-1 beta, and IL-6 but not IL-8 in the development of heat hyperalgesia: effects on heat-evoked calcitonin gene-related peptide release from rat skin. J. Neurosci. (2000) 20(16):6289-6293.
  • OBREJA O, SCHMELZ M, POOLE S, KRESS M: Interleukin-6 in combination with its soluble IL-6 receptor sensitises rat skin nociceptors to heat, in vivo. Pain (2002) 96(1-2):57-62.
  • DELEO JA, COLBURN RW, NLICHOIS M, MALHOTRA A: Interleukin-6-mediated hyperalgesia/allodynia and increased spinal IL-6 expression in a rat mononeuropathy model. J. Interferon Cytokine Res. (1996) 16(9):695-700.
  • ARRUDA JL, SWEITZER S, RUTKOWSKI MD, DELEO JA: Intrathecal anti-IL-6 antibody and IgG attenuates peripheral nerve injury-induced mechanical allodynia in the rat: possible immune modulation in neuropathic pain. Brain Res. (2000) 879(1-2):216-225.
  • RAMER MS, MURPHY PG, RICHARDSON PM, BISBY MA: Spinal nerve lesion-induced mechanoallodnia and adrenergic sprouting in sensory ganglia are attenuated in interleukin-6 knockout mice. Pain (1998) 78(2):115-121.
  • OBREJA O, BIASIO W, ANDRATSCH M et al.: Fast modulation of heat-activated ionic current by proinflammatory interleukin 6 in rat sensory neurons. Brain (2005) 128(7):1634-1641.
  • YU LC, HANSSON P, BRODDA-JANSEN G, THEODORSSON E, LUNDEBERG T: Intrathecal CGRP8-37-induced bilateral increase in hindpaw withdrawal latency in rats with unilateral inflammation. Br. J. Pharmacol. (1996) 117(1):43-50.
  • MURPHY PG, BORTHWICK LA, ALTARES M, GAULDIE J, KAPLAN D, RICHARDSON PM: Reciprocal actions of interleukin-6 and brain-derived neurotrophic factor on rat and mouse primary sensory neurons. Eur. J. Neurosci. (2000) 12(6):1891-1899.
  • FUKUOKA T, KONDO E, DAI Y, HASHIMOTO N, NOGUCHI K: Brain-derived neurotrophic factor increases in the uninjured dorsal root ganglion neurons in selective spinal nerve ligation model. J. Neurosci. (2001) 21(13):4891-4900.
  • ZHOU XF, CHIE ET, DENG YS et al.: Injured primary sensory neurons switch phenotype for brain-derived neurotrophic factor in the rat. Neuroscience (1999) 92(3):841-853.
  • YAJIMA Y, NARITA M, USUI A et al.: Direct evidence for the involvement of brain-derived neurotrophic factor in the development of a neuropathic pain-like state in mice. J. Neurochem. (2005) 93(3):584-594.
  • TOFARIS GK, PATTERSON PH, JESSEN KR, MIRSKY R: Denervated Schwann cells attract macrophages by secretion of leukemia inhibitory factor (LIF) and monocyte chemoattractant protein-1 in a process regulated by interleukin-6 and LIF. J. Neurosci. (2002) 22(15):6696-6703.
  • GIBSON SJ, POLAK JM, BLOOM SR et al.: Calcitonin gene-related peptide immunoreactivity in the spinal cord of man and of eight other species. J. Neurosci. (1984) 4(12):3101-3111.
  • BRAIN SD: Sensory neuropeptides: their role in inflammation and wound healing. Immunopharmacology (1997) 37(2-3):133-152.
  • WANG H, XING L, LI W, HOU L, GUO J, WANG X: Production and secretion of calcitonin gene-related peptide from human lymphocytes. J. Neuroimmunol. (2002) 130(1-2):155-162.
  • BRACCI-LAUDIERO L, ALOE L, BUANNE P et al.: NGF modulates CGRP synthesis in human B-lymphocytes: a possible anti-inflammatory action of NGF? J. Neuroimmunol. (2002) 123(1-2):58-65.
  • LI W, HOU L, HUA Z, WANG X: Interleukin-1beta induces beta-calcitonin gene-related peptide secretion in human Type II alveolar epithelial cells. FASEB J. (2004) 18(13):1603-1605.
  • BRACCI-LAUDIERO L, ALOE L, CAROLEO MC et al.: Endogenous NGF regulates CGRP expression in human monocytes and affects HLA-DR, B7 expression and IL-10 production. Blood (2005) 106(10):3507-3514.
  • MA W, BISBY MA: Calcitonin gene-related peptide, substance P and protein gene product 9.5 immunoreactive axonal fibers in the rat footpad skin following partial sciatic nerve injuries. J. Neurocytol. (2000) 29(4):249-262.
  • ZOCHODNE DW, ALLISON JA, HO W, HO LT, HARGREAVES K, SHARKEY KA: Evidence for CGRP accumulation and activity in experimental neuromas. Am. J. Physiol. (1995) 268(2 Pt 2):H584-H590.
  • POWELL KJ, MA W, SUTAK M, DOODS H, QUIRION R, JHAMANDAS K: Blockade and reversal of spinal morphine tolerance by peptide and non- peptide calcitonin gene-related peptide receptor antagonists. Br. J. Pharmacol. (2000) 131(5):875-884.
  • EDVINSSON L: Clinical data on the CGRP antagonist BIBN4096BS for treatment of migraine attacks. CNS. Drug Rev. (2005) 11(1):69-76.
  • CUESTA MC, QUINTERO L, PONS H, SUAREZ-ROCA H: Substance P and calcitonin gene-related peptide increase IL-1 beta, IL-6 and TNF alpha secretion from human peripheral blood mononuclear cells. Neurochem. Int. (2002) 40(4):301-306.
  • ZELENKA M, SCHAFERS M, SOMMER C: Intraneural injection of interleukin-1beta and tumor necrosis factor-alpha into rat sciatic nerve at physiological doses induces signs of neuropathic pain. Pain (2005) 116(3):257-263.
  • MA W, CHABOT JG, POWELL KJ, JHAMANDAS K, DICKERSON IM, QUIRION R: Localization and modulation of calcitonin gene-related peptide-receptor component protein-immunoreactive cells in the rat central and peripheral nervous systems. Neuroscience (2003) 120(3):677-694.
  • ZOCHODNE DW, HO LT: Hyperemia of injured peripheral-nerve – Sensitivity to CGRP antagonism. Brain Res. (1992) 598(1-2):59-66.
  • LOESCHER AR, BOISSONADE FM, ROBINSON PP: Calcitonin gene-related peptide modifies the ectopic discharge from damaged nerve fibres in the ferret. Neurosci. Lett. (2001) 300(2):71-74.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.